1. Abramov U, Raud S, Koks S, Innos J, Kurrikoff K, et al 2004. Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice. Behav Brain Res 155: 1–11.
2. Aquino CJ, Armour DR, Berman JM, Birkemo LS, Carr RAE, et al 1996. Discovery of 1,5‐benzodiazepines with peripheral cholecystokinin (CCK‐A) receptor agonist activity. 1. Optimization of the agonist “trigger”. J Med Chem 39: 562–569.
3. Baamonde A, Daugé V, Ruiz‐Gayo M, Fulga IG, Turcaud S, et al 1992. Antidepressant‐type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation. Eur J Pharmacol 216: 157–166.
4. Baber NS, Dourish CT, Hill DR. 1989. The role of CCK, caerulein, and CCK antagonists in nociception. Pain 39: 307–328.
5. Barrett RW, Steffey ME, Wolfram CAW. 1989. Type‐A CCK receptors in CHP 212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis. Mol Pharmacol 35: 394–400.